Angel Outlook: Technicals and Fundamentals Signal Weakness Despite Mixed Analysts

Angel Outlook: Technicals and Fundamentals Signal Weakness Despite Mixed AnalystsMarket SnapshotHeadline Takeaway: Angel (ANGX.N) has declined by -6.77% recently, and both technical and fundamental signals suggest caution.The technical side is weak, and it is suggested to avoid it, according to an internal diagnostic score of 2.53. Meanwhile, fundamental scores show mixed signals with an overall internal score of 0.39, pointing to potential vulnerabilities in revenue, net profit, and liquidity metrics.News Highlights On May 31, it was reported that Trump fast-tracked a Utah uranium mine, signaling broader industry revival potential. While this news pertains to a different sector, it could indirectly benefit Angel if mining-related policies gain momentum. A Supreme Court ruling on May 30 highlighted potential tax increases for OTT platforms and gaming apps, which may indirectly affect Angel’s business if it has digital advertising or media exposure. On May 29, changes to US vaccine policy were detailed, with implications for public health and government spending. While Angel is not directly in the vaccine space, policy shifts may influence broader economic and market sentiment.

Analyst Views & FundamentalsThe analyst consensus shows a simple average rating of 5.00 and a historical performance-weighted score of 0.00, indicating poor alignment between analyst expectations and real outcomes. Recent analyst activity has been mild, with Roth Capital's Eric Handler rating Angel as “Strong Buy” on May 16. However, this lone analyst has a historical win rate of 0.00% and average return of -5.52%, casting doubt on the strength of this recommendation. Analyst ratings are not consistent with the recent downward price trend of -6.77%.Key fundamental factor values and model scores: Revenue-MV: -0.60 (Internal diagnostic score: 2/10) Net profit attributable to parent company shareholders / Net profit (%): 99.98% (Internal diagnostic score: 0/10) Annualized return on equity (%): -902.13% (Internal diagnostic score: 0/10) Profit-MV: 47.43% (Internal diagnostic score: 1/10) Quick ratio: 107.41% (Internal diagnostic score: 1/10) PB-ROE: 390.57 (Internal diagnostic score: 2/10) Interest coverage ratio (EBIT / Interest expense) (%): -2065.91% (Internal diagnostic score: 0/10) ROE (%): -67660% (Internal diagnostic score: 0/10) Asset-MV: -44.18 (Internal diagnostic score: 0/10) Cash-MV: 44.01% (Internal diagnostic score: 2/10)Overall, the fundamentals do not support a bullish stance, with key metrics like ROE and interest coverage showing severe deterioration.Money-Flow TrendsAngel’s recent fund-flow data shows overall inflow ratios at 46.59% and a negative overall trend. Large and extra-large investors are pulling back, with inflow ratios at 48.77% and 45.21%, respectively, and a negative directional trend. In contrast, small investors remain slightly positive (51.72% inflow ratio). This suggests that institutional sentiment is bearish, while retail traders remain cautiously optimistic.Key Technical Signals Long Lower Shadow: internal diagnostic score of 1/10, with 28 historical signals and an average return of -5.99% and a 25.00% win rate. Long Upper Shadow: internal diagnostic score of 1/10, with 15 historical signals and an average return of -1.87% and a 26.67% win rate. Bearish Engulfing: internal diagnostic score of 5.6/10, with 3 historical signals and an average return of -15.32% and a 66.67% win rate.Over the past five days, Angel's chart has shown several bearish signals: 2025-12-19: Long Upper Shadow 2025-12-18: Long Upper Shadow, Shooting Star 2025-12-11: Bearish Engulfing 2025-12-12: Long Lower ShadowThese patterns suggest poor momentum and weak price action, with 2 bearish indicators and 0 bullish signals, reinforcing the technical bear case.ConclusionAngel (ANGX.N) faces a challenging outlook, with weak technicals, deteriorating fundamentals, and bearish fund flows. While one analyst has issued a “Strong Buy” rating, historical performance suggests caution. Investors are advised to consider waiting for a pull-back or clearer signals of recovery before engaging with this stock.